Paratek Pharmaceuticals (NASDAQ:PRTK) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Paratek Pharmaceuticals, Inc (NASDAQ:PRTK) Chairman Michael Bigham Sells 31,250 Shares modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
StockNews.com began coverage on shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Free Report) in a research report report published on Saturday. The brokerage issued a hold rating on the specialty pharmaceutical company’s stock. Several other research analysts have also issued reports on PRTK. Jefferies Financial Group lowered Paratek Pharmaceuticals from a buy rating to a hold […]
Trellus Management Company LLC lowered its position in shares of Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK – Free Report) by 56.9% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 127,000 shares of the specialty pharmaceutical company’s stock after selling 168,000 shares during the period. Trellus […]
StockNews.com upgraded shares of Paratek Pharmaceuticals (NASDAQ:PRTK – Get Rating) from a hold rating to a buy rating in a report published on Tuesday. A number of other equities research analysts have also commented on PRTK. BTIG Research reduced their price target on Paratek Pharmaceuticals from $24.00 to $5.00 in a research report on Tuesday, […]